Breastfeeding mothers : L-carnitine is likely safe for oral use during breastfeeding when consumed in the recommended dose by a healthcare professional
MT-II's published clinical-trial exposure is small
By staying informed (as you are by reading this!), practicing proactive symptom management, and working with your healthcare team, you can find the balance that lets you benefit from GLP-1 therapy while keeping IBS under good control
The Company is advancing NM-002, a proprietary long-acting GLP-1 agonist into a Phase 2 trial for short bowel syndrome (SBS), a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease
However, they are not a quick fix. The best outcomes come from combining medication with healthy eating, regular exercise, and ongoing medical supervision
In summary, the DPP-4 inhibitors have demonstrated cardiovascular safety in multiple studies